Binding Site’s Immunologicals Group introduced highly purified Borrelia and Chikungunya Glycoprotein antigens for use in both in-vitro diagnostic (IVD) manufacturing and research applications. The availability of the antigens is expected to benefit the needs of IVD assay manufacturers; clinical, biopharmaceutical, and life science researchers; and other allied health professionals, as the antigens have been expressly designed for…
Binding Site Expands Its Antibody And Antigen Offerings
Binding Site’s Immunologicals Group announced that it has just completed a major expansion to their antibody and antigen product offerings for human coagulation and complement applications. Both prothrombin and glycerol-free prothrombin proteins are available as antigens, while the antibody products include, but are not limited, to anti-human C1; C3; C4; C5; C8; factor H; factor I;…